Loading clinical trials...
Loading clinical trials...
Personalized Medicine in HCV Infection: Cognitive Impairments and Brain Anomalies in Chronic Hepatitis C Infected Individuals. Characterization and Potential Reversibility With Direct Antiviral Agents.
Conditions
Interventions
Neuropsychological evaluation and Brain MRI
Locations
1
Spain
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
Start Date
June 1, 2016
Primary Completion Date
December 1, 2017
Completion Date
December 1, 2017
Last Updated
April 21, 2016
NCT06953479
NCT03135886
NCT05968573
NCT05042544
NCT05870969
NCT05361603
Lead Sponsor
Instituto de Investigación Marqués de Valdecilla
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions